Authors:
EDNER M
BRODIN LA
ALKHALILI F
SVANE B
MOOR E
STAHLE A
NORDLANDER R
Citation: M. Edner et al., CHANGES IN SYSTOLIC AND DIASTOLIC FUNCTION INDEXES THROUGHOUT DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN HEALTHY-VOLUNTEERS AND PATIENTS WITH ISCHEMIC-HEART-DISEASE, Echocardiography, 15(7), 1998, pp. 625-634
Authors:
RUOTOLO G
ERICSSON CG
TETTAMANTI C
KARPE F
GRIP L
SVANE B
NILSSON J
DEFAIRE U
HAMSTEN A
Citation: G. Ruotolo et al., TREATMENT EFFECTS ON SERUM-LIPOPROTEIN LIPIDS, APOLIPOPROTEINS AND LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND RELATIONSHIPS OF LIPOPROTEIN VARIABLES TO PROGRESSION OF CORONARY-ARTERY DISEASE IN THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), Journal of the American College of Cardiology, 32(6), 1998, pp. 1648-1656
Authors:
ORTHGOMER K
HORSTEN M
WAMALA SP
MITTLEMAN MA
KIRKEEIDE R
SVANE B
RYDEN L
SCHENCKGUSTAFSSON K
Citation: K. Orthgomer et al., SOCIAL-RELATIONS AND EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE -THE STOCKHOLM-FEMALE-CORONARY-RISK-STUDY, European heart journal, 19(11), 1998, pp. 1648-1656
Authors:
NILSSON J
ERICSSON CG
HAMSTEN A
GRIP L
SVANE B
DEFAIRE U
Citation: J. Nilsson et al., BEZAFIBRATE FOLLOWING ACUTE MYOCARDIAL-INFARCTION - IMPORTANT FINDINGS FROM THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL, Fibrinolysis & proteolysis, 11, 1997, pp. 159-162
Authors:
DEFAIRE U
ERICSSON CG
GRIP L
NILSSON J
SVANE B
HAMSTEN A
Citation: U. Defaire et al., RETARDATION OF CORONARY ATHEROSCLEROSIS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT) AND OTHER ANGIOGRAPHIC TRIALS, Cardiovascular drugs and therapy, 11, 1997, pp. 257-263
Authors:
GRIP L
BLOMBACK M
EGBERG N
OLSSON A
SVANE B
VELANDER M
Citation: L. Grip et al., ANTITHROMBIN-III SUPPLEMENTATION FOR PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS - A CONTROLLED RANDOMIZED DOUBLE-BLIND PILOT-STUDY, European heart journal, 18(3), 1997, pp. 443-449
Authors:
ERICSSON CG
NILSSON J
GRIP L
SVANE B
HAMSTEN A
Citation: Cg. Ericsson et al., EFFECT OF BEZAFIBRATE TREATMENT OVER 5 YEARS ON CORONARY PLAQUES CAUSING 20-PERCENT TO 50-PERCENT DIAMETER NARROWING (THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL [BECAIT]), The American journal of cardiology, 80(9), 1997, pp. 1125-1129
Authors:
GRIP L
HELLEKANT C
HERZFELD I
MALMBERG K
SVANE B
SZAMOSI A
VELANDER M
RYDEN L
Citation: L. Grip et al., CORONARY ANGIOPLASTY IN PATIENTS WITH UNSTABLE ANGINA, WITH SPECIAL REFERENCE TO PRECEDING TREATMENT WITH ANTITHROMBIN-III AND HEPARIN, Clinical and applied thrombosis/hemostasis, 2(2), 1996, pp. 107-115
Authors:
DEFAIRE U
ERICSSON CG
GRIP L
NILSSON J
SVANE B
HAMSTEN A
Citation: U. Defaire et al., SECONDARY PREVENTIVE POTENTIAL OF LIPID-LOWERING DRUGS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), European heart journal, 17, 1996, pp. 37-42
Authors:
ERICSSON CG
HAMSTEN A
NILSSON J
GRIP L
SVANE B
DEFAIRE U
Citation: Cg. Ericsson et al., ANGIOGRAPHIC ASSESSMENT OF EFFECTS OF BEZAFIBRATE ON PROGRESSION OF CORONARY-ARTERY DISEASE IN YOUNG MALE POSTINFARCTION PATIENTS, Lancet, 347(9005), 1996, pp. 849-853
Authors:
ERICSSON CG
DEFAIRE U
GRIP L
HAMSTEN A
NILSSON J
SVANE B
Citation: Cg. Ericsson et al., BEZAFIBRATE RETARDS THE PROGRESSION OF CORONARY ATHEROSCLEROSIS MAINLY IN MILD-TO-MODERATE LESIONS - RESULTS OF FURTHER ANALYSES OF THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), Circulation, 94(8), 1996, pp. 3417-3417
Authors:
GRIP L
BLOMBACK M
EGBERG N
OLSSON A
SVANE B
VELANDER M
Citation: L. Grip et al., ANTITHROMBIN(III) SUPPLEMENTATION TO PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1250-1250
Citation: B. Axelsson et al., EVALUATION OF RADIATION EXPOSURE TO PERSONNEL IN CARDIAC ANGIOGRAPHY, Radiation protection dosimetry, 57(1-4), 1995, pp. 433-436
Citation: L. Grip et al., EXERCISE AND REDISTRIBUTION TL-201 MYOCARDIAL SCINTIGRAPHY - CHANGES IN DISTRIBUTION QUALITATIVELY UNAFFECTED BY PREVIOUS INFARCTION, Clinical physiology, 14(3), 1994, pp. 235-250